Rfg Advisory, LLC Abb Vie Inc. Transaction History

Rfg Advisory, LLC

$3.18 Billion
Q3 2024

A detailed history of Rfg Advisory, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Rfg Advisory, LLC holds 31,466 shares of ABBV stock, worth $5.51 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

31,466

Previous 32,900 4.36%

Holding current value

$5.51 Million

Previous $5.64 Million 10.1%

% of portfolio

0.2%

Previous 0.19%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	SELL	$163.84 - $199.33 $234,946 - $285,839	-1,434 Reduced 4.36%	31,466 $6.21 Million
Q2 2024 Jul 15, 2024	BUY	$154.79 - $180.76 $281,872 - $329,163	1,821 Added 5.86%	32,900 $5.64 Million
Q1 2024 Apr 11, 2024	SELL	$159.82 - $182.1 $384,686 - $438,314	-2,407 Reduced 7.19%	31,079 $5.66 Million
Q4 2023 Jan 25, 2024	SELL	$137.6 - $154.97 $44,582 - $50,210	-324 Reduced 0.96%	33,486 $5.19 Million
Q3 2023 Oct 16, 2023	BUY	$133.59 - $154.65 $292,695 - $338,838	2,191 Added 6.93%	33,810 $5.04 Million
Q2 2023 Aug 03, 2023	BUY	$132.51 - $164.9 $194,922 - $242,567	1,471 Added 4.88%	31,619 $4.26 Million
Q1 2023 May 09, 2023	BUY	$144.61 - $166.54 $52,059 - $59,954	360 Added 1.21%	30,148 $4.8 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $179,388 - $215,133	1,297 Added 4.55%	29,788 $4.82 Million
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $104,012 - $119,295	775 Added 2.8%	28,491 $4.23 Million
Q2 2022 Aug 09, 2022	SELL	$137.62 - $174.96 $164,731 - $209,427	-1,197 Reduced 4.14%	27,716 $3.83 Million
Q1 2022 May 11, 2022	SELL	$131.98 - $163.75 $460,610 - $571,487	-3,490 Reduced 10.77%	28,913 $4.69 Million
Q4 2021 Feb 02, 2022	BUY	$107.43 - $135.93 $11,280 - $14,272	105 Added 0.33%	32,403 $4.39 Million
Q3 2021 Oct 19, 2021	BUY	$106.4 - $120.78 $318,029 - $361,011	2,989 Added 10.2%	32,298 $3.48 Million
Q2 2021 Jul 29, 2021	BUY	$105.21 - $117.21 $168,336 - $187,536	1,600 Added 5.77%	29,309 $3.3 Million
Q1 2021 Apr 19, 2021	BUY	$102.3 - $112.62 $126,442 - $139,198	1,236 Added 4.67%	27,709 $3 Million
Q4 2020 Feb 02, 2021	BUY	$80.49 - $108.67 $48,937 - $66,071	608 Added 2.35%	26,473 $2.84 Million
Q3 2020 Oct 13, 2020	BUY	$85.91 - $100.83 $128,950 - $151,345	1,501 Added 6.16%	25,865 $2.27 Million
Q2 2020 Aug 03, 2020	BUY	$73.37 - $98.18 $158,846 - $212,559	2,165 Added 9.75%	24,364 $2.39 Million
Q1 2020 Apr 17, 2020	BUY	$64.5 - $97.79 $197,886 - $300,019	3,068 Added 16.04%	22,199 $1.69 Million
Q4 2019 Jan 22, 2020	BUY	$72.13 - $90.25 $98,457 - $123,191	1,365 Added 7.68%	19,131 $1.69 Million
Q3 2019 Nov 13, 2019	BUY	$62.98 - $75.72 $98,059 - $117,896	1,557 Added 9.61%	17,766 $1.35 Million
Q2 2019 Aug 23, 2019	BUY	$65.7 - $83.98 $794,050 - $1.01 Million	12,086 Added 293.14%	16,209 $1.18 Million
Q2 2019 Aug 15, 2019	SELL	$65.7 - $83.98 $633,019 - $809,147	-9,635 Reduced 70.03%	4,123 $302,000
Q1 2019 Apr 25, 2019	SELL	$77.14 - $90.79 $130,675 - $153,798	-1,694 Reduced 10.96%	13,758 $1.11 Million
Q4 2018 Feb 15, 2019	SELL	$77.85 - $96.01 $567,137 - $699,432	-7,285 Reduced 32.04%	15,452 $1.43 Million
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $2.02 Million - $2.25 Million	22,737 New	22,737 $2.15 Million
Q2 2018 Jul 25, 2018	SELL	$89.78 - $106.23 $1.27 Million - $1.51 Million	-14,190 Closed	0 $0
Q1 2018 May 10, 2018	SELL	$92.01 - $123.21 $2,668 - $3,573	-29 Reduced 0.2%	14,190 $1.34 Million
Q4 2017 Feb 08, 2018	BUY	$89.56 - $98.21 $25,345 - $27,793	283 Added 2.03%	14,219 $1.41 Million
Q3 2017 Nov 02, 2017	SELL	$69.85 - $89.22 $100,863 - $128,833	-1,444 Reduced 9.39%	13,936 $1.26 Million
Q2 2017 Aug 14, 2017	SELL	N/A	-670 Reduced 4.17%	15,380 $1.11 Million
Q1 2017 Nov 01, 2017	BUY	N/A	7,698 Added 92.17%	16,050 $1.04 Million
Q4 2016 Nov 01, 2017	BUY	N/A	8,352	8,352 $526,000

Others Institutions Holding ABBV

# of Institutions

3,855

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rfg Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rfg Advisory, LLC with notifications on news.

Account